Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- ILR7Independent statistical analysis of A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement: primary endpoint results, effect estimate with confidence interval, sample-size…
- IMAGEIndependent statistical analysis of A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): Complete Statistical AnalysisIndependent statistical analysis of Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Image Guidance for Improved Vessel Cannulation in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Image Guidance for Improved Vessel Cannulation in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04031495).
- Image Quality Assessment for Screening and Diagnostic Mammography: Complete Statistical AnalysisIndependent statistical analysis of Image Quality Assessment for Screening and Diagnostic Mammography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02786004).
- IMAGE-ACSIndependent statistical analysis of Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Image-guided Cryoablation of Head, Neck and Spine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Image-guided Cryoablation of Head, Neck and Spine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02085941).
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- IMAGINE 5Independent statistical analysis of A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Imaging Brain Tumors With FACBC and Methionine: Complete Statistical AnalysisIndependent statistical analysis of Imaging Brain Tumors With FACBC and Methionine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597246).
- Imaging Tau in Alzheimer’s Disease and Normal Aging: Complete Statistical AnalysisIndependent statistical analysis of Imaging Tau in Alzheimer's Disease and Normal Aging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03373604).
- iMALTIndependent statistical analysis of Improving Medication Adherence in Adolescents Who Had a Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03691220).
- IMARA-SA pilotIndependent statistical analysis of A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01781975).
- iMATRIXcobiIndependent statistical analysis of Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- IMIDIndependent statistical analysis of Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial: Complete Statistical AnalysisIndependent statistical analysis of Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis: Complete Statistical AnalysisIndependent statistical analysis of Immediate Fit Using Innovative Technology Transtibial & Transfemoral Prosthesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02886936).
- Immediate Loading and Fully Guided Surgery: Single Implants: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading and Fully Guided Surgery: Single Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061694).
- Immediate Loading Of Dental Implants: A Pilot Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Immediate Loading Of Dental Implants: A Pilot Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01644058).
- Immediate Postplacental IUD Insertion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Postplacental IUD Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02169869).
- Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: Complete Statistical AnalysisIndependent statistical analysis of Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Immersive Virtual Reality Bicycling for Persons With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05160025).
- Immersive Virtual Reality Exposure for Reducing Preoperative Anxiety in Children: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Exposure for Reducing Preoperative Anxiety in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07018999).
- Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Intervention for Non-Opioid Pain Management: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…
- IMMULAB – Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers: Complete Statistical AnalysisIndependent statistical analysis of Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants: Complete Statistical AnalysisIndependent statistical analysis of Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immune Response Following Seasonal Influenza Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Immune Response Following Seasonal Influenza Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03163342).
- Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease: Complete Statistical AnalysisIndependent statistical analysis of Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant: Complete Statistical AnalysisIndependent statistical analysis of Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578317).
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunization To Prevent Acute COPD Exacerbations: Complete Statistical AnalysisIndependent statistical analysis of Immunization To Prevent Acute COPD Exacerbations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03276754).
- Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients: Complete Statistical AnalysisIndependent statistical analysis of Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immuno-nutrition Supplementation in Haemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Immuno-nutrition Supplementation in Haemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05700851).
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunogenicity & Safety of GSK’s Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals’ Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above: primary endpoint…
- Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Immunogenicity and Safety of GSK Biologicals’ Influenza Vaccine Versus a Licensed Comparator in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…